Effects of a Classic High-frequency rTMS Treatment Versus a Deep rTMS Treatment
Launched by CENTRE HOSPITALIER HENRI LABORIT · Jun 29, 2021
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is investigating two types of brain stimulation treatments for adults aged 18 and older who are struggling with depression that hasn’t improved with standard medications. The goal is to see if a newer treatment called deep rTMS, which uses a helmet-shaped device to reach deeper parts of the brain, is more effective than the classic high-frequency rTMS treatment, which uses a different device shaped like an 8.
Participants in the study will receive either the classic rTMS treatment or the deep rTMS treatment, along with their usual therapy, over a total of 20 sessions, scheduled five times a week. They will also have three follow-up visits at 30, 60, and 90 days after starting treatment. To be eligible, individuals must be at least 18 years old, have a specific type of depression, and be on stable antidepressant medication for at least three weeks. However, some people may not qualify if they have certain severe mental health conditions, a history of seizures, or other medical issues that could complicate the treatment. This trial is currently recruiting participants, and it aims to provide hope for those who have not found relief from traditional depression treatments.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Volunteer subjects over 18 years old
- • Having signed a free and informed consent
- • Having a diagnostic of caracterised depressive episod recurrent or isolated according to DSM IV criteria (A.P.A 1994).
- • Having an antidepressant treatment not modified since 3 weeks
- • Score to MADRS scale ≥ 21
- • Subject affiliated to a social security regimen
- Exclusion Criteria:
- • Depression with psychotic caracteristics
- • Co-morbid diagnosis according to axis I (DSM IV) of schizophrenia, dependence (or abuse) on alcohol and / or another substance (lifetime)
- • Patient who has already undergone seismotherapy for current episode and non-responder to this treatment
- • Patient hospitalized under duress or under legal protection (guardianship, curatorship)
- • Patient with a high risk of suicide (item 10 of MADRS \> 4) in the absence of hospitalization.
- • Contra-indication for IRM exam or rTMS : personnal history of comitial crisis, of neurological or neurochirurgical pathologies, metallic prosthetic material or foreign body (pacemaker, intraoculare ferromagnetic material, implanted cardiac defibrillator, cochlear implant, metal clip
- • Pregnancy
- • Simultaneous participation to another interventionnal study
About Centre Hospitalier Henri Laborit
Centre Hospitalier Henri Laborit is a leading healthcare institution committed to advancing medical research and patient care through innovative clinical trials. With a focus on a multidisciplinary approach, the center integrates cutting-edge technology and evidence-based practices to investigate new treatments and improve health outcomes. The hospital collaborates with various stakeholders, including academic institutions and pharmaceutical companies, to ensure that its clinical studies are conducted with the highest standards of ethics and scientific rigor. By fostering a culture of collaboration and excellence, Centre Hospitalier Henri Laborit aims to contribute significantly to the field of medicine and enhance the quality of life for patients.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Poitiers, , France
Patients applied
Trial Officials
Ghina HARIKA-GERMANEAU, Dr
Principal Investigator
Centre Hospitalier Henri Laborit
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials